Identity
- Security key
- 19028
- Ticker
- NBP
- Type
- ADRC — American Depository Receipt Common
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-01-17
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- NBP
Detail
Enriched 2026-08-14 20:47
- Market cap
- $216,262,704.35
- Shares outstanding (class)
- 115,648,505
- Shares outstanding (weighted)
- 115,648,505
- SIC
- —
- Employees
- 30
- Location
- —
- Homepage
- https://www.novabridge.com
- Description
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.